The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.42
Bid: 8.20
Ask: 8.40
Change: 0.00 (0.00%)
Spread: 0.20 (2.439%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 8.42
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Solar Foods Raises an Additional EUR8 Million

26 Apr 2024 07:00

RNS Number : 0577M
Agronomics Limited
26 April 2024
 

 

26 April 2024

Agronomics Limited

("Agronomics" or the "Company")

Solar Foods Raises an Additional EUR8 Million in New Financing

Agronomics (LSE:ANIC), a leading listed company focused on the field of cellular agriculture, is pleased to announce that portfolio company Solar Foods Oy ("Solar Foods") has raised an additional EUR8 million in funding via Finnish investment organiser Springvest Oyj.

 

This additional funding is a subsequent close to Solar Food's Series B round which took place in November 2023, bringing the total raise to EUR16 million. Solar Foods' first commercial-scale factory, named Factory 01, has been fully operational since April this year and is expected to produce 160 tons of Solein™ annually. Solar Foods has already achieved regulatory approval for Solein™ in Singapore and is currently in partnership with the Finnish food company, Oy Karl Fazer AB, which is incorporating Solein into a chocolate snack. Solar Foods has also submitted a dossier to the European Food Safety Authority and is in conversations with multiple potential customers for the integration of Solein™ into existing product lines.

 

To date, Agronomics has invested EUR6 million in Solar Foods. As disclosed in Agronomics' Unaudited Interim Results, this position is currently carried at a book value of £11.4 million, including an uplift of £6.3 million. This subsequent raise remained on the same terms as those set in November and there is no change to the value of Agronomics position.

 

Agronomics' Executive Chair, Jim Mellon commented:

 

"Solar Foods has shown impressive execution with the funds they have raised to date. It is one of the few companies in this field with a wholly owned and fully operational factory and regulatory approval which puts Solar Foods as one of the most advanced cell ag companies globally. We are very much looking forward to seeing product sales begin in Singapore and for regulatory approval in Europe."

 

About Solar Foods

Solar Foods produces protein using carbon dioxide and electricity. Solein™ production, irrespective of weather and climate conditions, liberates global protein production from the constraints of traditional agriculture. Solar Foods, founded in 2017 in Espoo, Finland by Dr Pasi Vainikka, Dr Juha-Pekka Pitkänen, Sami Holmström, Jari Tuovinen, Professor Jero Ahola, and Janne Mäkelä as a spinoff from VTT Technical Research Centre of Finland and LUT University. www.solarfoods.com.

 

About Solein

Solein™ is a microbial protein-rich powder that contains all the essential amino acids. It is produced using a bioprocess where microbes are fed with gases, including carbon dioxide, hydrogen, and oxygen, together with small amounts of nutrients. The bioprocess resembles winemaking, with carbon dioxide and hydrogen replacing sugar as the source of carbon and energy.

This type of production method has the potential to transform the sustainability, availability, and transparency of what we eat and where food can be produced. It is not reliant on agriculture, weather, or climate: it can be produced in harsh conditions such as deserts, Arctic areas, even space. Learn more about Solein™ at www.solein.com.

About Agronomics

Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture including precision fermentation and cultivated meat. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

For further information please contact:

Agronomics

Limited

Beaumont

Cornish Limited

Canaccord Genuity Limited

Cavendish Capital Markets Limited

Peterhouse Capital

Limited

SEC Newgate

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

Alex Aylen

Giles Balleny

Michael Johnson

Charlie Combe

Lucy Williams

Charles Goodfellow

Bob Huxford Anthony Hughes

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

agronomics@secnewgate.co.uk

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFISEIEFIS
Date   Source Headline
26th Apr 20247:00 amRNSSolar Foods Raises an Additional EUR8 Million
22nd Apr 20247:00 amRNSAgronomics Newsletter
17th Apr 20247:00 amRNSMosa Meat Raises EUR 40 Million in New Financing
12th Apr 20247:00 amRNSExercise of Warrants
10th Apr 20249:30 amRNSPortfolio Company Presentation Series – Onego Bio
5th Apr 20247:00 amRNSAgronomics Invests US$10m in Liberation Labs
2nd Apr 20247:00 amRNSOnego Bio Raises EUR37 Million
26th Mar 20247:09 amRNSClean Food secures £2.5m additional funding
21st Mar 20245:40 pmRNSSuperMeat Update
20th Mar 202410:37 amRNSFormo Update
18th Mar 20247:00 amRNSMeatly Creates Cans of Cultivated Pet Food
13th Mar 20247:00 amRNSShiok Meats Merges with Umami Bioworks
21st Feb 20247:00 amRNSAgronomics Newsletter
14th Feb 20247:00 amRNSCalifornia Cultured Update
14th Feb 20247:00 amRNSUnaudited Interim Results
9th Feb 20247:00 amRNSNet Asset Value calculation as at 31 December 2023
8th Feb 202412:15 pmRNSResult of AGM
8th Feb 20247:00 amRNSPerformance Shares issued to Shellbay Investments
6th Feb 20247:00 amRNSBond Pet Foods Achieves Key Milestone
18th Jan 20247:00 amRNSIsraFirst Regulatory Approval for Cultivated Beef
10th Jan 202412:32 pmRNSAgronomics Newsletter
10th Jan 20247:00 amRNSExercise of Warrants and TVR
28th Dec 202312:36 pmRNSNew Website and Corporate Presentation
27th Dec 20231:16 pmRNSHolding(s) in Company
27th Dec 20237:00 amRNSFinal Results
14th Dec 20237:00 amRNSJim Mellon appointed Executive Chairperson
5th Dec 20233:28 pmRNSInvestee Company Update: Clean Food Group
1st Dec 20237:00 amRNSInvestee Company Update: Clean Food Group
1st Dec 20237:00 amRNSLiberation Labs secures US$ 25 million loan
22nd Nov 20235:05 pmRNSHolding(s) in Company
16th Nov 20232:05 pmRNSSolar Foods Completes EURO 8m Series B Financing
13th Nov 20237:00 amRNSInvestee Company Update: Good Dog Food
9th Nov 20238:09 amRNSUpdate regarding Joint Broker
3rd Nov 20237:05 amRNSNAV calculation as of 30 September 2023
1st Nov 20237:00 amRNSBlueNalu Update: NEOM Signs MoU with BlueNalu
17th Oct 20237:00 amRNSPortfolio Company Update: All G Foods
12th Oct 20239:47 amRNSExercise of Warrants & Total Voting Rights
9th Oct 20237:00 amRNSBlue Naln raises US$33.5m in Series B priced round
22nd Sep 20237:00 amRNSShare Buyback Programme announced
7th Sep 20237:00 amRNSPortfolio Company Update: SuperMeat
21st Aug 20237:00 amRNSPortfolio Company Good Dog Food Update
17th Aug 20237:00 amRNSCellX Opens Chinese Cultivated Meat Pilot Factory
14th Aug 20237:00 amRNSCFG completes £2.3 Million Pre-Series A Financing
9th Aug 20231:06 pmRNSREPLACEMENT: Meatable completes EUR30m funding
8th Aug 20239:05 amRNSMeatable completes EUR35M Series B Financing Round
8th Aug 20238:21 amRNSClean Food Group Collaboration with Alianza
2nd Aug 20237:00 amRNSNet Asset Value calculation at 30 June 2023
18th Jul 20239:14 amRNSFormo Successful Tasting Event
18th Jul 20237:00 amRNSFormo Successful Tasting Event
18th Jul 20237:00 amRNSPortfolio Company Update: Galy Co. Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.